NanoPacific Holdings

NanoPacific Holdings is a biotechnology company focused on the development and commercialization of advanced nanotechnology for targeted drug delivery. Based in Los Angeles, the company maintains a strategic partnership with the California NanoSystems Institute (CNSI) at UCLA, from which it has exclusively licensed key intellectual property. Its core technology involves "mechanized nanoparticles" or nanomachines capable of storing and selectively releasing therapeutic agents, such as chemotherapeutics, directly into cancer cells. This platform aims to enhance the efficacy of existing drugs while significantly reducing systemic toxicity and side effects. Beyond oncology, the company explores applications for its nanoemulsion and polypeptide technologies in diagnostics, cosmetics, and industrial sectors.